- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 489-503 of
973 results
1091 Exhibit: Declaration of Melissa Weinberg, MD
Document
IPR2024-00107, No. 1091 Exhibit - Declaration of Melissa Weinberg, MD (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1066 Exhibit: Knudsen, Liraglutide The Therapeutic Promise from Animal Models, 6...
Document
IPR2024-00107, No. 1066 Exhibit - Knudsen, Liraglutide The Therapeutic Promise from Animal Models, 64suppl (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1044 Exhibit: Rohatagi, Model Based Development of a PPARγ Agonist, Rivoglitazo...
Document
IPR2024-00107, No. 1044 Exhibit - Rohatagi, Model Based Development of a PPARγ Agonist, Rivoglitazone, to Aid (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1036 Exhibit: Mojsov, Insulinotropin Glucagon like Peptide I 7 37 Co encoded in the...
Document
IPR2024-00107, No. 1036 Exhibit - Mojsov, Insulinotropin Glucagon like Peptide I 7 37 Co encoded in the Gl (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1094 Exhibit: CV of Craig Dyar, PhD
Document
IPR2024-00107, No. 1094 Exhibit - CV of Craig Dyar, PhD (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
... of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00107, No. 2028 Exhibit - EX2028 Excerpt of Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 030
|
|
Cite Document
... of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00107, No. 2030 Exhibit - EX2030 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 0303
|
|
Cite Document
1056 Exhibit: US Patent No 5,118,666
Document
IPR2024-00107, No. 1056 Exhibit - US Patent No 5,118,666 (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1016 Exhibit: US Patent Application Pub No US20070010424
Document
IPR2024-00107, No. 1016 Exhibit - US Patent Application Pub No US20070010424 (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1019 Exhibit: Bell, Hamster Preproglucagon Contains the Sequence of Glucagon a...
Document
IPR2024-00107, No. 1019 Exhibit - Bell, Hamster Preproglucagon Contains the Sequence of Glucagon and Two Rela (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1039 Exhibit: Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010
Document
IPR2024-00107, No. 1039 Exhibit - Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010 (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1093 Exhibit: Declaration of Craig Dyar, PhD
Document
IPR2024-00107, No. 1093 Exhibit - Declaration of Craig Dyar, PhD (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
1098 Exhibit: Oral Order, Novo Nordisk Inc v Rio Biopharmaceuticals Inc, No 22 29...
Document
IPR2024-00107, No. 1098 Exhibit - Oral Order, Novo Nordisk Inc v Rio Biopharmaceuticals Inc, No 22 294 CFC D Del March 13, 2024 (P.T.A.B. Mar. 15, 2024)
|
|
Cite Document
... William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00107, No. 2029 Exhibit - EX2029 Excerpt of Opening Expert Report of William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22
|
|
Cite Document
1030 Exhibit: Kim, Effects of Once Weekly Dosing of a Long Acting Release Formul...
Document
IPR2024-00107, No. 1030 Exhibit - Kim, Effects of Once Weekly Dosing of a Long Acting Release Formulation of (P.T.A.B. Nov. 2, 2023)
|
|
Cite Document
